Maintenance therapy with rituximab leads to a significant prolongation of response duration after salvage therapy with a combination of rituximab, fludarabine, cyclophosphamide, and mitoxantrone (R-FCM) in patients with recurring and refractory follicular and mantle cell lymphomas: results of a prospective randomized study of the German Low Grade Lymphoma Study Group (
GLSG).
GLSG Newsletter for the Gay & Lesbian Study Group of the American Musico- logical Society (ISSN 1087-8564), has a new title, The Newsletter for the LGBTQ Study Group of the American Musicological Society (ISSN 1556-0406), beginning with volume 15, number 2 (semiannual).